Abstract:OBJECTIVE:To evaluate the safety and validity of neo-adjuvant chemoradiotherapy followed by surgery for locally advanced esophageal carcinoma.METHODS:Patients with IIB, III staged squamous cell carcinoma of thoracic esophagus were randomly allocated to either preoperative chemoradiotherapy followed by surgery (arm A) or surgery alone (arm B). In arm A, chemotherapy and radiotherapy were performed concurrently. Patients received two cycles of vinorelbine and cisplatin. Vinorelbine at 25 mg/m(2) per day was administered as a bolus infusion at d1, d8, d22 and d29. Cisplatin at 75 mg/m(2) was administered by an intravenous infusion at d1 and d22 (or 25 mg/m(2) days 1 - 4 and 22 - 25). A total radiotherapeutic dose of 40 Gy was delivered in 20 daily fractions of 2.0 Gy each (5 d/wk for 4 weeks). Three-incisioned esophagectomy was performed at Weeks 4 - 6 after chemoradiotherapy. Primary outcome was overall survival time. An interim analysis was performed in June 2011.RESULTS:From July 2007 to June 2011, 123 eligible patients were randomly assigned at 7 cooperative cancer centers (54 cases in arm A vs 69 cases in arm B). In arm A, the clinical response rate of chemoradiotherapy was 90.7%. All patients finished the preoperative chemoradiotherapy. Forty-nine cases continued to receive esophagectomy. The pathological complete response rate was 29.6%. The rate of R0 resection in arm A was significant higher than that in arm B(96.0% vs 85.5%, P = 0.015). The most common grade 3/4 toxicity of chemoradiotherapy was leukopenia occurring in 33 cases (61.1%). Vomiting and esophagitis were usually of Grade 1/2. No patient died or abandoned surgery because of chemoradiation toxicity. Between arms A and B, operative duration, blood loss, duration of chest tube drainage and length of postsurgical hospital stay were similar. The incidences of postoperative heart failure (2.0% vs 1.4%, P = 1.000), anastomotic leakage (8.2% vs 11.6%, P = 0.759) and hoarseness (6.1% vs 4.3%, P = 0.691) were not significantly different. The incidence of pulmonary infection in arm A was slightly higher than that in arm B (8.2% vs 1.4%, P = 0.094). No perioperative deaths occurred in either group. There were no significant differences in overall survivals at 1, 2 years between arms A and B (85.6%/75.5% vs 79.1%/66.1%, P = 0.207). The disease-free survivals at 1, 2 years in arm A were slightly higher than in arm B (86.6%/83.2% vs 70.9%/61.8%, P = 0.075).CONCLUSION:Neo-adjuvant chemoradiation followed by surgery may achieve a high clinical response rate and pathologic complete tumor regression rate. It significantly increases the R0 resection rate and down stage the esophageal cancer patients. But its ultimate efficacy awaits further follow-up studies.

Observation of preliminary therapeutic effects of surgical excision combined with interstitial chemotherapy on 21 cases of oral squamous cell carcinoma

Short Term Therapeutic Effect on Treatment of Postoperational Large Intestine Carcinoma by Fupiyiwei Decoction Combined with Chemotherapy and It's Effect on Immune Fuction

Evaluation of the Chemotherapy Effect in Advanced Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography

Effects of Traditional Chinese Medicine Anticancer Decoction Combined with Basic Chemotherapy and Nursing Intervention on Oral Cancer Patients after Surgery and Its Effect on Tumor Markers and Immune Function

Study of drug distribution in tissue during treatment with targeting and continuous interstitial chemotherapy in the oral squamous cell carcinoma

Intermediate and Long-Term Therapeutic Effect Analysis of Preoperative Induction Chemotherapy As Comprehensive Therapy in Healing Oral Squamous Cell Carcinoma

Clinical observation of "Fuzheng Quyu Jiedu Prescription" combining with chemotherapy in treating postoperative breast cancer

Primary study of the tongue squamous cell carcinoma treated with targeting and continuous interstitial chemotherapy

Neoadjuvant Chemotherapy for Locally Advanced Squamous Carcinoma of Oral Cavity: a Pilot Study

A Clinical Study on Apoptosis and Proliferation of Gastric Adenocarcinoma Cells Induced by 5'-Deoxy-5-fluorouridine (5'-DFUR)

S-1 Plus Docetaxel and Cisplatin As an Induction Chemotherapy for Advanced Oral Squamous Cell Carcinoma: A Clinical Observation

Curative Effect Observation of Concurrent Chemoradiotherapy Before Colorectal Cancer Surgery

Effect on Survival of Postoperative Therapy in Patients with Primary Small Cell Carcinoma of Esophagus (scce): an Analysis of Multicenter Clinical Outcomes.

Randomized controlled study on preoperative concurrent chemoradiotherapy versus surgery alone for esophageal squamous cell carcinoma

High Intensity Focused Ultrasound in Combination with Chemotherapy: A Clinical Study for Advanced Malignancy of Digestive System

Clinical Effect of Breast Conserving Surgery Combined with Neoadjuvant Chemotherapy Treatment for Breast Cancer

Effects of Tongluo Jiedu prescription on immune function and oxidative stress in patients with oral cancer

[A Multi-Centered Randomized Controlled Study of Neo-Adjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of Esophagus: an Interim Analysis].

Clinical Observation of Early Postoperative Chemotherapy Combined with Traditional Chinese Medicine Adjuvant Therapy for Gastric Carcinoma

Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy

Recent Curative Effect Observation of Sustained-release 5-Fluorouracil Used during Operation in Patients with Advanced Ovarian Elithelial Carcinoma